Back to top
Zanamivir for system suitability

Zanamivir for system suitability

Product Details:

  • Molecular Weight 332.31 Grams (g)
  • Usage Zanamivir. Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza.
  • Melting Point 325oC
  • Purity 95%
  • Molecular Formula C12H20N4O7
  • Click to View more
X

Zanamivir for system suitability Price And Quantity

  • 1 Kilograms
  • 10 INR

Zanamivir for system suitability Product Specifications

  • Zanamivir. Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza.
  • 332.31 Grams (g)
  • C12H20N4O7
  • 325oC
  • 95%

Zanamivir for system suitability Trade Information

  • Cash in Advance (CID) Cash Advance (CA)
  • 500 Kilograms KG Per Month
  • 2-8 Week
  • Yes
  • Sample costs shipping and taxes has to be paid by the buyer
  • Carton and Poly Bag.
  • Western Europe Australia Eastern Europe Middle East Central America Africa South America Asia North America
  • All India

Product Description

Zanamivir for system suitability

  • Synonym: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid, 4-Guanidino-Neu5Ac2en, Zanamivir

    • Empirical Formula (Hill Notation): C12H20N4O7

    • Molecular Weight: 332.31

    • CAS Number: 139110-80-8

 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Analytical Grade Chemicals' category